结直肠癌患者癌结节的研究现状

doi:10.3760/cma.j.issn.1673-422X.2016.11.018

国际肿瘤学杂志 ›› 2016, Vol. 43 ›› Issue (11): 868-870.doi: 10.3760/cma.j.issn.1673-422X.2016.11.018

结直肠癌患者癌结节的研究现状

刘洪雁，李云峰，陈洪刚，杨国春

250031 济南，山东省医学科学院附属医院急诊科（刘洪雁、陈洪刚、杨国春）；昆明医科大学第三附属医院大肠癌临床研究中心（李云峰）

收稿日期:2016-03-07 出版日期:2016-11-08 发布日期:2016-11-02
通讯作者: 杨国春，Email: ykyfsyyjzk2014@163.com E-mail:ykyfsyyjzk2014@163.com
基金资助:
山东省医学科学院院级科技计划（2015-60）

Research status of tumor nodules in colorectal cancer

Liu Hongyan, Li Yunfeng, Chen Honggang, Yang Guochun

Emergency Department, Affiliated Hospital of Shandong Academy of Medical Sciences, Ji′nan 250031, China

Received:2016-03-07 Online:2016-11-08 Published:2016-11-02
Contact: 杨国春，Email: ykyfsyyjzk2014@163.com E-mail:ykyfsyyjzk2014@163.com
Supported by:
Science and Technology Program of Shandong Academy of Medical Sciences (2015-60)

摘要/Abstract

摘要： 癌结节的形成与淋巴结转移、神经侵犯和脉管侵犯有关。癌结节是结直肠癌患者的一个不利预后因素，增加结直肠癌患者复发转移的概率。纳入淋巴结转移计数后评估预后的价值大于七版癌结节分期方法，可为结直肠癌患者的临床治疗提供更精准的依据。

关键词: 结直肠肿瘤, 预后, 癌结节

Abstract: The formation of tumor nodules is related to lymph node metastasis, neural invasion and vascular invasion. Tumor nodule is a negative prognostic factor in colorectal cancer patients, which increases the probability of recurrence and metastasis in patients with colorectal cancer. The prognostic value of tumor nodules in the lymph node metastasis is greater than the seventh edition of tumor nodules staging method, which provides a more accurate basis for the clinical treatment.

Key words: Colorectal neoplasms, Prognosis, Tumor nodules

刘洪雁，李云峰，陈洪刚，杨国春. 结直肠癌患者癌结节的研究现状[J]. 国际肿瘤学杂志, 2016, 43(11): 868-870.

Liu Hongyan, Li Yunfeng, Chen Honggang, Yang Guochun. Research status of tumor nodules in colorectal cancer[J]. Journal of International Oncology, 2016, 43(11): 868-870.

参考文献

［1］ Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014［J］. CA Cancer J Clin, 2014, 64(1): 9-29. DOI: 10.3322/caac.21208. ［2］ Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual［M］. 7th ed. New York: Springer, 2010. ［3］ Wünsch K, Müller J, Jhnig H, et al. Shape is not associated with the origin of pericolonic tumor deposits［J］. Am J Clin Pathol， 2010， 133(3): 388-394. DOI: 10.1309/AJCPAWOLX7ADZQ2K. ［4］ Fan XJ, Wan XB, Yang ZL, et al. Snail promotes lymph node metastasis and Twist enhances tumor deposit formation through epithelialmesenchymal transition in colorectal cancer［J］. Hum Pathol, 2013, 44(2): 173-180. DOI: 10.1016/j. humpath. 2012.03.029. ［5］ Zhang D, Zheng L, Shi H, et al. Suppression of peritoneal tumorigenesis by placentaderived mesenchymal stem cells expressing endostatin on colorectal cancer［J］. Int J Med Sci, 2014, 11(9): 870-879. DOI: 10.7150/ijms.8758. ［6］ Koelzer VH, Lugli A, Dawson H, et al. CD8/CD45RO T cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival［J］. J Transl Med, 2014, 12: 81. DOI: 10.1186/1479-5876-12-81. ［7］ Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging handbook［M］. 6th ed. New York: Springer, 2002: 104-109. ［8］ Song YX, Gao P, Wang ZN, et al. Can the tumor deposits be counted as metastatic lymph nodes in the UICC TNM staging system for colorectal cancer?［J］. PLoS One, 2012, 7(3): e34087. DOI: 10.1371/journal.pone.0034087. ［9］ Ueno H, Mochizuki H, Shirouzu K, et al. Multicenter study for optimal categorization of extramural tumor deposits for colorectal cancer staging［J］. Ann Surg, 2012, 255(4): 739-746. DOI: 10.1097/SLA.0b013e31824b4839. ［10］ Ueno H1, Mochizuki H, Shirouzu K, et al. Actual status of distribution and prognostic impact of extramural discontinuous cancer spread in colorectal cancer［J］. J Clin Oncol, 2011, 29(18): 25502556. DOI: 10.1200/JCO.2010.33.7725. ［11］ Nagtegaal ID,Tot T,Jayne DG, et al. Lymph nodes, tumor deposits, and TNM: are we getting better?［J］. J Clin Oncol, 2011, 29(18): 2487-2492. DOI: 10.1200/JCO.2011.34.6429. ［12］ Ueno H, Hashiguchi Y, Shimazaki H, et al. Peritumoral deposits as an adverse prognostic indicator of colorectal cancer［J］. Am J Surg, 2014, 207(1): 7077. DOI: 10.1016/j.amjsurg. 2013.04.009. ［13］ Tong LL, Gao P, Wang ZN, et al. Is the seventh edition of the UICC/AJCC TNM staging system reasonable for patients with tumor deposits in colorectal cancer?［J］. Ann Surg, 2012, 255(2): 208-213. DOI: 10.1097/SLA.0b013e31821ad8a2. ［14］ Nagayoshi K, Ueki T, Nishioka Y, et al. Tumor deposit is a poor prognostic indicator for patients who have stage Ⅱ and Ⅲ colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more［J］. Dis Colon Rectum, 2014, 57(4): 467-474. DOI: 10.1097/DCR.0000000000000059. ［15］ Lin Q, Wei Y, Ren L, et al. Tumor deposit is a poor prognostic indicator in patients who underwent simultaneous resection for synchronous colorectal liver metastases［J］. Onco Targets Ther, 2015, 8: 233-240. DOI: 10.2147/OTT.S71414.eCollection 2015. ［16］ Song JS, Chang HJ, Kim DY, et al. Is the N1c category of the new American Joint Committee on cancer staging system applicable to patients with rectal cancer who receive preoperative chemora therapy?［J］. Cancer, 2011, 117(17): 3917-3924. DOI: 10.1002/cncr.25968. ［17］ Gopal P, Lu P, Ayers GD, et al. Tumor deposits in rectal adenocarcinoma after neoadjuvant chemoradiation are associated with poor prognosis［J］. Mod Pathol, 2014, 27(9): 1281-1287. DOI: 10.1038/modpathol.2013.239.

[1]	钱晓涛, 石子宜, 胡格, 吴晓维. Ⅲ~ⅣA期食管鳞状细胞癌放化疗后行巩固化疗的疗效：一项真实世界临床研究[J]. 国际肿瘤学杂志, 2024, 51(6): 326-331.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[4]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[5]	范志鹏, 余静, 胡静, 廖正凯, 徐禹, 欧阳雯, 谢丛华. 炎症标志物的变化趋势对一线接受免疫联合化疗的晚期非小细胞肺癌患者预后的预测价值[J]. 国际肿瘤学杂志, 2024, 51(5): 257-266.
[6]	杨琳, 路宁, 温华, 张明鑫, 朱琳. 炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[7]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝. 癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[8]	刘萍萍, 何学芳, 张翼, 杨旭, 张珊珊, 季一飞. 原发性脑胶质瘤患者术后复发危险因素及预测模型构建[J]. 国际肿瘤学杂志, 2024, 51(4): 193-197.
[9]	万芳, 杨钢, 李睿, 万启晶. 食管癌患者血清miR-497、miR-383水平及临床意义[J]. 国际肿瘤学杂志, 2024, 51(4): 204-209.
[10]	姚益新, 沈煜霖. 血清SOCS3、TXNIP水平对肝细胞癌TACE治疗预后的预测价值[J]. 国际肿瘤学杂志, 2024, 51(4): 217-222.
[11]	孙维蔚, 姚学敏, 王鹏健, 王静, 贾敬好. 基于血液学指标探讨免疫治疗晚期非小细胞肺癌预后因素及列线图构建[J]. 国际肿瘤学杂志, 2024, 51(3): 143-150.
[12]	刘玉兰, 井海燕, 孙静, 宋伟, 沙丹. 胃癌免疫治疗疗效预测及预后标志物的研究进展[J]. 国际肿瘤学杂志, 2024, 51(3): 175-180.
[13]	彭琴, 蔡玉婷, 王伟. KPNA2在肝癌中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(3): 181-185.
[14]	孙国宝, 杨倩, 庄庆春, 高斌斌, 孙晓刚, 宋伟, 沙丹. 结直肠癌肝转移组织病理学生长方式研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 114-118.
[15]	陈波光, 王苏贵, 张永杰. 血清胆碱酯酶与炎症标志物在ⅠA~ⅢA期乳腺癌预后中的作用[J]. 国际肿瘤学杂志, 2024, 51(2): 73-82.

结直肠癌患者癌结节的研究现状

Research status of tumor nodules in colorectal cancer

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价